HOME
>
Investors
>
Investor Relations
>
IR Presentation
Title
Content
2
2Q 2011 Earnings
2011-07-29
1
Poised for Growth
2010-04-13
1
Vaccines
Cardiovascular treatment
Endocrine treatment
Anti-infective teatment
Oncology teatment
Hyaluronic acid product
